Pharmacokinetics and bioequivalence of the main metabolites of selegiline: desmethylselegiline, methamphetamine and amphetamine after oral administration of selegiline.
A bioavailability study of 2 different selegiline preparations were conducted in 20 healthy volunteers to test the bioequivalence. Almost no bioavailability study of selegiline has been published. As plasma levels of selegiline are very low and the elimination half-life is very short being about 9 minutes, therefore, a very sensitive and selective method for determining the 3 main metabolites desmethylselegiline (DMS), methamphetamine (MA) and amphetamine (A) was developed. After application of a single oral dose of 5 mg selegiline the Cmax values of DMS reached 5-6 ng/ml, of MA 6-7 ng/ml and of A about 2 ng/ml. The AUC infinity values were with DMS about 11 ng/ml x h +/- 4.5, with MA about 130 g/ml x h +/- 50 and with A about 50 ng/ml x h +/- 15. The 90% confidence interval was with logarithmic transformed AUC infinity values 92-107% with DMS, 89-107% with MA, and 84-104% with A. The logarithmic transformed Cmax values showed a 90% confidence interval of 92-127% with DMS, 91-101% with MA, and 90-103% with A. All relevant pharmacokinetic parameters showed bioequivalence with all 3 metabolites (DMS, MA, and A).
Mascher
H J
HJ
Pharm-analyt Laboratory GmbH, Baden, Austria.
Kikuta
C
C
Millendorfer
A
A
Schiel
H
H
Ludwig
G
G
D000284:Administration, Oral; D000328:Adult; D000661:Amphetamine / Q000493:pharmacokinetics*; D000662:Amphetamines / Q000493:pharmacokinetics*; D001682:Biological Availability; D000697:Central Nervous System Stimulants / Q000493:pharmacokinetics*; D006207:Half-Life; D006801:Humans; D008297:Male; D008694:Methamphetamine / Q000493:pharmacokinetics*; D008996:Monoamine Oxidase Inhibitors / Q000008:administration & dosage / Q000378:metabolism* / Q000493:pharmacokinetics; D012642:Selegiline / Q000008:administration & dosage / Q000378:metabolism* / Q000493:pharmacokinetics; D013810:Therapeutic Equivalency
D000662:Amphetamines; D000697:Central Nervous System Stimulants; D008996:Monoamine Oxidase Inhibitors; D012642:Selegiline; D008694:Methamphetamine; C017861:desmethylselegiline; D000661:Amphetamine